Most Recent Articles about GSK
Novartis' (NVS) BLA for Ophthalmology Drug Accepted by FDA Apr 16, 2019 - The FDA accepts Novartis' (NVS) BLA seeking approval for brolucizumab for the treatment of wet AMD.
Clovis Stalls Mid-Stage Rubraca Study for Bladder Cancer Apr 15, 2019 - Clovis Oncology (CLVS) halts mid-stage bladder cancer study evaluating Rubraca monotherapy. It is unlikely to provide meaningful clinical benefit as reviewed by an independent data monitoring committee.
Merck's Keytruda Gets FDA Nod for Expanded Lung Cancer Group Apr 12, 2019 - Merck (MRK) gets FDA approval to include overall survival data from the KEYNOTE-042 study on Keytruda's label.

Related Companies

Name Exchange Price Mkt Cap
AZN Astrazeneca PLC NYSE $37.56 $95.16B
BMY Bristol-Myers Squibb Company NYSE $61.3 $100.03B
SNY Sanofi NYSE $43.75 $109.14B
LLY Eli Lilly and Company NYSE $105.71 $113.53B
NVO Novo Nordisk A/S NYSE $47.64 $114.84B
Sector: Health Care > Industry: Major Pharmaceuticals